Global Europe Dog Dewormers Market Overview
According to SPER Market Research, the Europe Dog Dewormers Market is estimated to reach USD 1.09 billion by 2032 with a CAGR of 10.89%.
The term "deworming" refers to the use of anthelmintic drugs to rid dogs of parasitic worms like roundworms, hookworms, tapeworms, whipworms, and heartworms. "Deworming medications' mechanisms of action vary, as do the parasites they eliminate," Hutchison explains. "Some cause muscle spasms, which paralyse the worm and allow the gastrointestinal tract to get rid of it. Regular faecal exams, which aid in the diagnosis of various types of intestinal worms, go hand in hand with deworming. The frequency with which your veterinarian requests a faecal sample will be determined by several factors, including local disease prevalence and your dog's lifestyle, but you should generally expect to send a sample once or twice a year.
Impact of COVID-19 on the Europe Dog Dewormers Market
The spread of the COVID-19 pandemic halted the region's research and development, medical supply, and veterinary services in almost every part of Europe. Following WHO's declaration of COVID-19 as a pandemic due to its widespread transmission, European countries such as Russia, the United Kingdom, and Germany, among others, declared a total lockdown to halt the spread. As a result, the animal healthcare industry, like many others, has been significantly impacted. COVID-19's market consequences include a decrease in veterinary clinic admission rates and supply chain disruptions for dewormer products. However, with the help of e-commerce channels, the relaxation of COVID-19 restrictions, and the resumption of veterinary services in late 2020, the dog dewormer market regained growth in Europe.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Target Worms, By Distribution Channel
|
| Regions covered | Czech, Denmark, France, Germany, Hungary, Ireland, Italy, Norway, Poland, Portugal, Romania, Slovakia, Spain, Sweden, United Kingdom
|
| Companies Covered | Merck & Co., Inc., Boehringer Ingelheim International GmbH, Virbac, Elanco, Ceva, Zoetis, PetIQ, LLc, Sava Healthcare Limited, Beaphar, Drontal Plus. |
Europe Dog Dewormers Market Segmentation:
1. By Target Worms:
- Roundworms
- Hookworms
- Tapeworms
- Heartworms
- Whipworms
2. By Distribution Channel:
- Veterinary Clinics
- Pet Stores
- Online Retailing
3. By Region:
- Czech
- Denmark
- France
- Germany
- Hungary
- Ireland
- Italy
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Spain
- Sweden
- United Kingdom
Key Topics Covered in the Report:
- Size of Europe Dog Dewormers Market (FY’2019-FY’2032)
- Overview of Europe Dog Dewormers Market
- Segmentation of Europe Dog Dewormers Market By Target Worms (Roundworms, Hookworms, Tapeworms, Heartworms, Whipworms)
- Segmentation of Europe Dog Dewormers Market By Distribution Channel (Veterinary Clinics, Pet Stores, Online Retailing)
- Statistical Snap of Europe Dog Dewormers Market
- Growth Analysis of Europe Dog Dewormers Market
- Problems and Challenges in Europe Dog Dewormers Market
- Competitive Landscape in the Europe Dog Dewormers Market
- Impact of COVID-19 and Demonetization on Europe Dog Dewormers Market
- Details on Recent Investment in Europe Dog Dewormers Market
- Competitive Analysis of Europe Dog Dewormers Market
- Major Players in the Europe Dog Dewormers Market
- SWOT Analysis of Europe Dog Dewormers Market
- Europe Dog Dewormers Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Europe Dog Dewormers Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Europe Dog Dewormers Market Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Dog Dewormers Market
7. Europe Dog Dewormers Market, By Target Worms, 2019-2032 (USD Million)
7.1 Roundworms
7.2 Hookworms
7.3 Tapeworms
7.4 Heartworms
7.5 Whipworms
8. Europe Dog Dewormers Market, By Distribution Channel, 2019-2032 (USD Million)
8.1 Veterinary Clinics
8.2 Pet Stores
8.3 Online Retailing
9. Europe Dog Dewormers Market, By Region, 2019-2032 (USD Million)
9.1 Europe Dog Dewormers Market Size and Market Share by Region (2019-2025)
9.2 Europe Dog Dewormers Market Size and Market Share by Region (2026-2032)
9.3 Czech
9.4 Denmark
9.5 France
9.6 Germany
9.7 Hungary
9.8 Ireland
9.9 Italy
9.10 Norway
9.11 Poland
9.12 Portugal
9.13 Romania
9.14 Slovakia
9.15 Spain
9.16 Sweden
9.17 United Kingdom
10. Company Profiles
10.1 Beaphar
10.1.1 Company details
10.1.2 Financial outlook
10.1.3 Product summary
10.1.4 Recent developments
10.2 Boehringer Ingelheim International GmbH
10.2.1 Company details
10.2.2 Financial outlook
10.2.3 Product summary
10.2.4 Recent developments
10.3 Ceva
10.3.1 Company details
10.3.2 Financial outlook
10.3.3 Product summary
10.3.4 Recent developments
10.4 Drontal Plus
10.4.1 Company details
10.4.2 Financial outlook
10.4.3 Product summary
10.4.4 Recent developments
10.5 Elanco
10.5.1 Company details
10.5.2 Financial outlook
10.5.3 Product summary
10.5.4 Recent developments
10.6 Merck & Co., Inc.,
10.6.1 Company details
10.6.2 Financial outlook
10.6.3 Product summary
10.6.4 Recent developments
10.7 PetIQ, LLc
10.7.1 Company details
10.7.2 Financial outlook
10.7.3 Product summary
10.7.4 Recent developments
10.8 Sava Healthcare Limited
10.8.1 Company details
10.8.2 Financial outlook
10.8.3 Product summary
10.8.4 Recent developments
10.9 Virbac
10.9.1 Company details
10.9.2 Financial outlook
10.9.3 Product summary
10.9.4 Recent developments
10.10 Zoetis
10.10.1 Company details
10.10.2 Financial outlook
10.10.3 Product summary
10.10.4 Recent developments
11. List of Abbreviations
12. Reference Links
13. Conclusion
14. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
